Coldizin will be sold under private label as a food supplement, and marketed throughout the country through Negma’s sales and marketing organization. The launch is planned for the fourth quarter of 2008.
Danilo Copiz, Scandinavian Clinical Nutrition’s (SCN’s) vice president of sales, said: “This is a great opportunity for Coldizin. The product has strong scientific documentation and patent protection, and Negma’s experience of selling high-quality products and their nation-wide distribution makes them an ideal distribution partner.”